Neuropace shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Neuropace by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $84k | 12k | 6.97 |
2024-06-30 | $44k | 5.8k | 7.56 |
2024-03-31 | $424k | 32k | 13.20 |
2023-12-31 | $117k | 11k | 10.31 |
2022-03-31 | $27k | 3.3k | 8.11 |
2021-12-31 | $50k | 5.0k | 10.10 |